Charles Asare

653 total citations · 1 hit paper
5 papers, 497 citations indexed

About

Charles Asare is a scholar working on Rheumatology, Physiology and Surgery. According to data from OpenAlex, Charles Asare has authored 5 papers receiving a total of 497 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Rheumatology, 2 papers in Physiology and 1 paper in Surgery. Recurrent topics in Charles Asare's work include Asthma and respiratory diseases (2 papers), Spondyloarthritis Studies and Treatments (1 paper) and Monoclonal and Polyclonal Antibodies Research (1 paper). Charles Asare is often cited by papers focused on Asthma and respiratory diseases (2 papers), Spondyloarthritis Studies and Treatments (1 paper) and Monoclonal and Polyclonal Antibodies Research (1 paper). Charles Asare collaborates with scholars based in United States, Canada and Italy. Charles Asare's co-authors include Akihito Yokoyama, Kun Peng, Saloumeh K Fischer, Eric D. Bateman, Petr Kopecký, Julie Olsson, John G. Matthews, Nicola A. Hanania, Pierluigi Paggiaro and Kenneth R. Chapman and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Lancet Respiratory Medicine and Journal of Dermatological Treatment.

In The Last Decade

Charles Asare

4 papers receiving 479 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials

2016 350 citations Nicola A. Hanania, Phillip E. Korenblat et al. The Lancet Respiratory Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Charles Asare United States	3	299	222	178	148	97	5	497
Müge Bıçakçıgil Türkiye	8	82 0.3×	95 0.4×	131 0.7×	157 1.1×	19 0.2×	11	379
M.G. Sabbadini Italy	9	115 0.4×	103 0.5×	76 0.4×	151 1.0×	11 0.1×	12	342
Naoto Azuma Japan	10	74 0.2×	75 0.3×	58 0.3×	110 0.7×	12 0.1×	46	313
Adam Adler United States	7	100 0.3×	112 0.5×	93 0.5×	102 0.7×	11 0.1×	10	381
F Liozon France	11	53 0.2×	69 0.3×	263 1.5×	209 1.4×	38 0.4×	49	384
B. Guglielmi Italy	7	263 0.9×	119 0.5×	71 0.4×	206 1.4×	11 0.1×	10	414
Pavel Novikov Russia	10	53 0.2×	64 0.3×	273 1.5×	152 1.0×	11 0.1×	77	377
P Lesavre France	9	82 0.3×	142 0.6×	186 1.0×	124 0.8×	6 0.1×	29	392
Milena Bond Italy	11	48 0.2×	86 0.4×	166 0.9×	159 1.1×	11 0.1×	32	378
Malvina A. Krupiczojc United Kingdom	4	57 0.2×	40 0.2×	223 1.3×	22 0.1×	18 0.2×	5	409

Countries citing papers authored by Charles Asare

Since Specialization

Citations

This map shows the geographic impact of Charles Asare's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Asare with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Asare more than expected).

Fields of papers citing papers by Charles Asare

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles Asare. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Asare. The network helps show where Charles Asare may publish in the future.

Co-authorship network of co-authors of Charles Asare

This figure shows the co-authorship network connecting the top 25 collaborators of Charles Asare. A scholar is included among the top collaborators of Charles Asare based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles Asare. Charles Asare is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Asare, Charles, et al.. (2020). The Effect of Supply Chain Management Practices on Performance of SMEs in SekondiTakoradi Metropolis of Ghana. SHILAP Revista de lepidopterología.

2.

Hanania, Nicola A., Phillip E. Korenblat, Kenneth R. Chapman, et al.. (2016). Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials. The Lancet Respiratory Medicine. 4(10). 781–796. 350 indexed citations breakdown →

3.

Hanania, Nicola A., Phillip E. Korenblat, Kenneth R. Chapman, et al.. (2016). LATE-BREAKING ABSTRACT: LAVOLTA I and II: Results of 2 phase III studies to assess the efficacy and safety of lebrikizumab in patients with uncontrolled asthma. OA1975–OA1975. 1 indexed citations

4.

Gottlieb, Alice B., Philip J. Mease, J. Mark Jackson, et al.. (2006). Clinical characteristics of psoriatic arthritis and psoriasis in dermatologists' offices. Journal of Dermatological Treatment. 17(5). 279–287. 70 indexed citations

5.

Haraoui, Boulos, Edward Keystone, Carter Thorne, et al.. (2004). Clinical outcomes of patients with rheumatoid arthritis after switching from infliximab to etanercept.. PubMed. 31(12). 2356–9. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact